SCHEMBL9380302

SCHEMBL9380302

C#CCn1c(=O)n(C)c2ccccc21

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.70
▸ ALDH1A1 P00352 3/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ TSHR P16473 4/20 0.51
▸ NPC1 O15118 3/20 0.51
▸ LMNA P02545 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ PARG Q86W56 1/20 0.49
▸ AGER Q15109 1/20 0.49
▸ GAA P10253 1/20 0.48
▸ POLB P06746 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ ADORA3 P0DMS8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9378270 0.83 KDM4E (0.56) CYP1A2MEN1KMT2ATSHRLMNA
SCHEMBL5286253 0.77 CYP1A2 (0.62) CYP1A2ALDH1A1MEN1KMT2ATSHR
SCHEMBL9380812 0.76 ADORA3 (0.53) CYP1A2L3MBTL1ADORA3
SCHEMBL24665898 0.76 CYP1A2 (0.61) CYP1A2ALDH1A1MEN1KMT2ATSHR
SCHEMBL10807639 0.76 CYP1A2 (0.61) CYP1A2ALDH1A1MEN1KMT2ATSHR
SCHEMBL22899000 0.74 ADORA2B (0.49) CYP1A2PARGADORA3
SCHEMBL22899003 0.74 ADORA2B (0.49) CYP1A2PARGADORA3
SCHEMBL6955745 0.74 CYP1A2 (0.59) CYP1A2ALDH1A1MEN1KMT2ATSHR
SCHEMBL11098187 0.74 CYP1A2 (0.59) CYP1A2ALDH1A1MEN1KMT2ATSHR
SCHEMBL16822023 0.74 CYP1A2 (0.59) CYP1A2ALDH1A1MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0320992-B1 Triazolodiazepine derivatives HOFFMANN LA ROCHE (CH) 1994-07-27 — — EP disclosed
US-4959361-A Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists HOFFMANN-LA ROCHE INC. (US) 1990-09-25 — — US disclosed
EP-0320992-A2 Triazolodiazepine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1989-06-21 — — EP disclosed
Send feedback